MTOR and pulmonary fibrosis: Anti-fibrotic effects of mTOR inhibitors have been extensively reported in patients with hepatic or pulmonary fibrosis and rheumatic diseases14–17; however, to the best of our knowledge, no report has yet discussed the potential effects of mTOR inhibitors on hTM cells.